Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05433220 · ClinicalTrials.gov registry record · NA
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova
A NA study of Heart Failure, sponsored by Inova Health Care Services.
- Recruiting
- Registry status
- NA
- Development phase
- 5,000
- Enrollment target
- 1
- Study location
NCT05433220: Recruiting NA study of Heart Failure, sponsored by Inova Health Care Services.
NCT05433220 is a NA study of Heart Failure that is actively recruiting participants, run by Inova Health Care Services. The registered enrollment target is 5,000 participants, above the 2,036-participant average among 397 other Heart Failure trials with a reported enrollment target (146% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05433220, a NA study of Heart Failure, is actively recruiting participants, sponsored by Inova Health Care Services.
- RECRUITING
- Registry status
- NA
- Development phase
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, single-blind intervention trial to test the comparative effectiveness of an electronic health record best practice advisory system that informs clinicians of guideline-indicated and FDA-approved heart failure medications currently not prescribed to their patients with heart failure versus usual care (no alert and how things are done currently). The purpose of the alert is to stimulate appropriate medication prescription for patients with heart failure and a reduced ejection fraction. This will be done across outpatient Inova clinics and at the five Inova hospitals.
Primary Outcome
The primary outcome for the trial will be the proportion of patients with HFrEF who have an increase in the number of prescribed evidence-based therapies for HFrEF (beta-blockers, ACE-I/ARB/ARNI, MRA, SGLT2i) 30 days after randomization.
Conditions Studied
Interventions
- OTHER Best Practice Advisory using Electronic Health Record
Study Locations (1)
Virginia
- Inova Health System - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2022-08-25 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT05433220 shows while recruiting
NCT05433220 is an interventional study that assigns participants to a tested intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,036-participant average among 397 other Heart Failure trials with a reported enrollment target (146% higher).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Best Practice Advisory using Electronic Health Record is the first listed.
NCT05433220 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05433220 about?
NCT05433220 is a clinical study titled "PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova". A randomized, single-blind intervention trial to test the comparative effectiveness of an electronic health record best practice advisory system that informs clinicians of guideline-indicated and FDA-approved heart failure medications currently not prescribed to their patients with heart failure ver...
What is the current status of trial NCT05433220?
This trial is currently recruiting. It is a NA study. The enrollment target is 5,000 participants. The study started on 2022-08-25. Estimated completion is 2026-08.
What conditions does trial NCT05433220 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT05433220?
The interventions under investigation include: Best Practice Advisory using Electronic Health Record (OTHER).
Who is sponsoring clinical trial NCT05433220?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05433220 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05433220's enrollment target sits among peer trials
5,000 19th of 397 higher than 374 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI